Clinical Trial Update: Mass Balance Study of [14C]HRS9531 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 mass balance study of [14C]HRS9531 in healthy male subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• HRS9531

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus, Weight Loss | Phase 1 | Status: COMPLETED